Successful autologous stem cell transplantation in Gaucher disease patient with multiple myeloma

American Journal of Hematology

Volumn 86, Issue 6, 2011, Pages 529-530

  Aubourg, Alexandre ^a   Benboubker, Lotfi ^a   Picon, Laurence ^a   Goupille, Philippe ^a   Maillot, Francois ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGLUCERASE; DEXAMETHASONE; DOXORUBICIN; IMIGLUCERASE; VINCRISTINE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BONE TUMOR; CANCER RADIOTHERAPY; ENZYME REPLACEMENT; GAUCHER DISEASE; HEPATOSPLENOMEGALY; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

GAUCHER DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSPLANTATION, AUTOLOGOUS;

EID: 79956084024     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22028     Document Type: Letter

References (12)

1. Costello R, O'Callaghan T, Sebahoun R. Gaucher disease and multiple myeloma. Leukemia Lymphoma 2006; 47: 1365-1368.
2. Hughes D, Cappellini MD, Berger M, et al. Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease. Br J Haematol 2007; 138: 676-686.
3. Rosenbloom BE, Weinreb NJ, Zimran A, et al. Gaucher disease and cancer incidence: A study from the Gaucher Registry. Blood 2005; 105: 4569-4572.
4. de Fost M, vom Dahl S, Weverling GJ, et al. Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 2006; 36: 53-58.
5. Taddei TH, Kacena KA, Yang M, et al. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients. Am J Hematol 2009; 84: 208-214.
6. Pratt PW, Estren S, Kochwa S. Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases. Blood 1968; 31: 633-640.
7. Marti GE, Ryan ET, Papadopoulos NM, et al. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol 1988; 29: 189-194.
8. Gery I, Zigler JS, Brady RO, et al. Selective effects of glucocerebroside (Gaucher's storage material) on macrophages cultures. J Clin Invest 1981; 68: 1182-1189.
9. Allen MJ, Myer BJ, Khokher AM, et al. Proinflammatory cytokines and the pathogenesis of Gaucher's disease: Increased release of interleukine-6 and interleukine-10. Q J Med 1997; 90: 19-25.
10. Brautbar A, Elstein D, Pines G, et al. Effect of enzyme replacement therapy on gammopathies in Gaucher disease. Blood Cells Mol Dis 2004; 32: 214-217.
11. Grosbois B, Rose C, Noël E, et al. Gaucher disease and monoclonal gammopathy: A report of 17 cases and impact of therapy. Blood Cells Mol Dis 2009; 43: 138-139.
12. Lo SM, Stein P, Mullaly S, et al. Expanding spectrum of association between type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types-correlation with genotype and phenotype. Am J Hematol 2010; 85: 340-345.